- Corticosteroids for acute chest syndrome in children with sickle cell disease: variation in use and association with length of stay and readmissionAmy Sobota
Division of Hematology Oncology, Children s Hospital Boston, 300 Longwood Avenue, Boston, MA 02115, USA
Am J Hematol 85:24-8. 2010..6-3.4), adjusted for confounding. Hospitals vary greatly in the use of corticosteroids for ACS, even in patients with asthma. Clear evidence of the efficacy and toxicity of corticosteroid treatment in ACS may reduce variation in care...
- Quality of life in thalassemia: a comparison of SF-36 results from the thalassemia longitudinal cohort to reported literature and the US normsA Sobota
Children s Hospital Boston, Massachusetts, USA
Am J Hematol 86:92-5. 2011..The SF-36 should become a standard instrument for assessing HRQOL in thalassemia to determine predictors of low HRQOL which may be better addressed by a multidisciplinary team...
- Thirty-day readmission rates following hospitalization for pediatric sickle cell crisis at freestanding children's hospitals: risk factors and hospital variationAmy Sobota
Division of Hematology Oncology, Children s Hospital Boston, Boston, Massachusetts, USA
Pediatr Blood Cancer 58:61-5. 2012..Readmission within 30 days after hospitalization for sickle cell crisis was developed by The National Association of Children's Hospitals (NACHRI) to improve hospital quality, however, there have been few studies validating this...